Search

everythinglearnresearchcommunity

for

Search:↓

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

CLE40 and CRN/CLV2 pathways have opposite effects on root growth in Arabidopsis.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Cepharanthine shows promise as a COVID-19 treatment.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Finasteride may help improve certain brain function issues linked to dopamine.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

RXRα is crucial for proper immune response and links diet to immune function.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Low power red laser with efavirenz can reduce HIV-1 infection to undetectable levels and improve diagnosis.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Enhancing Tregs can protect against alopecia areata.

Tislelizumab can cause cutaneous lupus erythematosus.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Blocking mTORC1 reduces skin tumor growth in mice.

CRF can cause hair loss, but blocking its receptors might prevent this.